Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Schlumberger (SLB)

SLB completes all-stock ChampionX acquisition at 0.735 SLB shares per share

Neutral Impact 4 of 5 m&a Written later

SLB closed its acquisition of ChampionX Corporation on July 16, 2025, in an all-stock deal in which each ChampionX share was exchanged for 0.735 SLB common shares. Former ChampionX shareholders now own approximately 9% of SLB's outstanding common stock, and SLB expects about $400 million in annual pretax synergies within three years of closing.

Key points

  • Each ChampionX share exchanged for 0.735 SLB common shares, with cash in lieu of fractional shares
  • Former ChampionX shareholders own approximately 9% of SLB's outstanding common stock
  • SLB expects annual pretax synergies of approximately $400 million within three years post-closing
  • SLB remains on track to return $4 billion to shareholders in 2025

The filing

CompanySchlumberger (SLB)
Form8-K, current report
Filed with the SECJul 16, 2025, 4:06 PM ET
Accession number0001193125-25-159859

Items reported: 2.01 Acquisition or Disposition Completed7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 16, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.